MeSH tree: C12.050.351.500.852.593
Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from over-the-counter and prescription medications that treat high cholesterol and pain to protection from infectious ...
Mar 31, 2025
0
16
At-home self-sampling cervical screening looks likely to be an option in the future. But scientists warn that steps must be taken to ensure that the offer of at-home sampling doesn't have a negative impact on cervical screening ...
Mar 31, 2025
0
7
When a person dies, clinicians often look at the cause of death to determine whether it could have been avoided, either by medical prevention such as vaccines or by treatments like antibiotics. These types of deaths are known ...
Mar 24, 2025
0
108
Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, ...
Mar 17, 2025
0
15
The incidence of and mortality from cervical cancer are higher among rural-residing women versus their urban counterparts within the United States, according to a research letter published online March 3 in JAMA Network Open.
Mar 7, 2025
0
14
People with intellectual disabilities (ID) are significantly less likely to participate in population-based cancer screening than the general population, according to researchers from Radboudumc and the academic collaborative ...
Mar 4, 2025
0
18
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for evaluating ...
Feb 14, 2025
0
16
Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be responsible for more than 99% of cervical cancers. HPV screening usually entails a speculum-based exam, ...
Feb 13, 2025
0
22
Human Papilloma Virus (HPV) self-sampling promises to make the process of screening for cervical cancer easier, more comfortable—and, for some, less traumatic—than a traditional Pap test, offering users more control over ...
Jan 28, 2025
0
29
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase II clinical trial published in Clinical Cancer Research.
Jan 24, 2025
0
32
